CO-ADD screening of MMV (CH) - Pandemic Response Box
2021
Type: DATASET, Abstract: This data set was generated by screening MMV Pandemic Response Box compounds in the CO-ADD assays. CO-ADD, The Community for Open Antimicrobial Drug Discovery, is a global open-access screening initiative launched in February 2015 to uncover significant and rich chemical diversity held outside of corporate screening collections. CO-ADD provides unencumbered free antimicrobial screening for any interested academic researcher. CO-ADD has been recognised as a novel approach in the fight against superbugs by the Wellcome Trust, who have provided funding through their Strategic Awards initiative (for more information on CO-ADD see: Helping Chemists Discover New Antibiotics (2015) Mark A. Blaskovich, Johannes Zuegg, Alysha G. Elliott, Matthew A. Cooper, DOI:10.1021/acsinfecdis.5b00044)., Authors: Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper